Clicky

Locale : English
X
Create document Page
added
Remove
page
Add
page
Review document
/
Page Added
Collected
Pages
Create
Release
14 May 2009

Mott MacDonald to design new £45m pharmaceutical facility in Cheshire

Mott MacDonald, the global engineering, management and development consultancy has been appointed by AstraZeneca UK* to design a major new four-storey research and development facility at the company’s site at Alderley Park, Cheshire, UK. Mott MacDonald will be providing structural, civil and architectural design, as well as overall design coordination and construction support for the project as part of an alliance framework.**

The building will house several research departments including a pre-clinical imaging facility, and will replace and expand existing facilities on site which are being demolished as part of the project. Demolition material will be crushed on site and re-used to create the new buildings.

Chris Oakes, Mott MacDonald’s project manager explained, “This is an important facility for AstraZeneca, and the design brief was necessarily complex to accommodate the pharmaceutical capabilities. As a result Mott MacDonald was required to have an understanding of the company’s complex inter-departmental relationships and specialist operations. The design will be modelled using three-dimensional design software complete with clash detection٭ and walk-through capability to provide detailed visualisations of the completed building. This approach will be used to carry out design co-ordination between the other design consultants and equipment vendors.”

He added, “The site is located in the centre of a very busy operational research and development facility, so from a construction viewpoint minimal disruption to existing operations and services will be a key requirement of the project.”

Ends


Notes to editors


* AstraZeneca is one of the world’s leading pharmaceutical companies, with a broad range of medicines designed to fight disease in important areas of healthcare: gastrointestinal, cardiovascular, neuroscience, respiratory, cancer and infection. Backed by strong science and wide-ranging commercial skills, we are committed to sustainable development of our business and the delivery of a flow of new medicines that bring benefit for patients and add value for wider society.

** The project is being procured utilising AstraZeneca preferred design and installation contractors in an alliance framework arrangement. The alliance contractors will identify and table project risks during the design process prior to sanction, which will provide the basis for the future commercial management of the project using key performance indicators.

٭Clash detection is a design tool that helps to identify where possible clashes may occur between different elements of the project (for example structure and ventilation systems) during the design stage, so as to prevent clashes on site.
icon-arrow-down-smlicon-arrow-left-lrgicon-arrow-left-smlicon-arrow-right-lrgicon-arrow-right-smlicon-arrow-up-smlicon-championsicon-closeicon-downloadicon-educationicon-emailicon-grid-viewicon-languageicon-link-toicon-list-viewicon-locationicon-login-registericon-minusicon-moreicon-phoneicon-plusicon-recently-viewedicon-searchicon hashkey-facts-corner-sashquote-underlinesocial-icon-facebooksocial-icon-googleplussocial-icon-linkedinsocial-icon-twittersocial-share-icon-facebooksocial-share-icon-facebooksocial-share-icon-googleplussocial-share-icon-googleplussocial-share-icon-instagramsocial-share-icon-instagramsocial-share-icon-linkedinsocial-share-icon-linkedinsocial-share-icon-twittersocial-share-icon-twittersocial-share-icon-youtubesocial-share-icon-youtubesina-weiboMM-Shape01-Quote-ViewsMM-Shape03-Quote-LocationsMM-Shape05-Quote-ProjectsMM-Shape12-Quote-SectorsMM-Shape13-Quote-ExpertiseMM-Shape14-Quote-About-UsMM-Shape14-Quote-Careerscheckmarkicon-expand-viewicon-apply-nowmenusphereicon-cookiesicon-legalicon-registered-companiestarget